Johnson & Johnson (J&J) operates in the pharmaceutical industry within the healthcare sector. J&J’s latest fiscal year ended on December 31, 2012 in which it reported revenues of $67.224 billion with a five-year revenue CAGR of 1.93%. The company’s net income for the same year was $10.85bn and operating margins were 25.34%. Johnson & Johnson divides its business into three segments which are, Consumer Healthcare, Pharmaceuticals and Medical Devices & Diagnostics (MD&D). The largest segment by revenue in 2012 was MD&D with Pharmaceuticals in second. The company has a 50-year record of increased dividend payments and its dividend yield was 2.8%.